Is Ioduro sodico (131 I) [INN-Spanish] Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Ioduro sodico (131 I) [INN-Spanish]? Is Ioduro sodico (131 I) [INN-Spanish] safe for nursing mother and child? Does Ioduro sodico (131 I) [INN-Spanish] extracts into breast milk? Does Ioduro sodico (131 I) [INN-Spanish] has any long term or short term side effects on infants? Can Ioduro sodico (131 I) [INN-Spanish] influence milk supply or can Ioduro sodico (131 I) [INN-Spanish] decrease milk supply in lactating mothers?

Information in this record refers to the use of Ioduro sodico (131 I) [INN-Spanish] as a diagnostic and therapeutic agent. The use of I 131 is contraindicated during lactation.[1] Breastfeeding should be discontinued permanently for this child after administration of Ioduro sodico (131 I) [INN-Spanish] in a dose of 0.01 MBq (0.004 mCi) or greater to a nursing mother.[2][3][4][5][6] Ceasing breastfeeding at least 4 weeks before receiving a therapeutic dose of Ioduro sodico (131 I) [INN-Spanish] is recommended to reduce the radiation dose to the breasts and the risk of milk leakage that can contaminate clothing with radioactive iodine.[4][7][8] The American Thyroid Association recommends using I 123 or Tc99m pertechnetate scans for diagnosis of hyperthyroidism in nursing mothers.[1] Parents should refrain from close contact with their infants after therapeutic iodine 131 administration. The exact duration depends on the dose administered, condition being treated, and source of the recommendation.[2][9][10] Recommended times range from 15 to 27 days after hyperthyroidism treatment, 16 to 24 days after ablation of thyroid cancer, and 4 to 5 days after follow-up therapy of thyroid ablation therapy.[10]